PRO/AMR> Surveillance (197): South Korea, M. pneumoniae, macrolide resist. & co-infection
Reply-To: noreply@isid.org
SURVEILLANCE (197): SOUTH KOREA, MYCOPLASMA PNEUMONIAE, MACROLIDE
RESISTANCE AND CO-INFECTION TRENDS, EPIDEMIC, 2019-20
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org
Date: Mon 13 Nov 2023
Source: Antibiotics [edited]
https://doi.org/10.3390/antibiotics12111623
Citation: Shin S, Koo S, Yang Y-J, Lim H-J. Characteristics of the
Mycoplasma pneumoniae epidemic from 2019 to 2020 in Korea: macrolide
resistance and co-infection trends. Antibiotics. 2023; 12(11): 1623.